HIV-AIDS, Sexually Transmitted Disease (STD) and Hepatitis Reports

Reports for HIV-AIDS, Sexually Transmitted Diseases (STDs), and Hepatitis can be accessed in the tabs below. Many reports include a combination as the burden of these infections is related.

ARE YOU AT RISK? Millions of Americans have VIRAL HEPATITIS. Most don't know it. Take this online assessment to see if you're at risk. //’t find what you were looking for? Contact us at to request additional Hepatitis data.

HIV/AIDS Annual Reports

Note: In December 2016, the Virginia Department of Health (VDH) HIV Surveillance team completed a series of death matches and address updates to the Enhanced HIV/AIDS Reporting System (eHARS). These updates to the HIV surveillance system resulted in a reduction of 601 cases of persons living with HIV in Virginia as of December 31, 2015 from the 2015 Annual Report to the 2016 Annual Report. These quality assurance checks are completed annually to more accurately define the HIV epidemic in Virginia and to better assess health outcomes for all persons living with HIV in the Commonwealth. All 2016 data is considered preliminary and may be incomplete due to reporting delay.

HIV Epidemiology Profile

2017 Updates:

2016 Virginia HIV Epidemiologic Profile | 2015 | 2014 |

HIV Continuum of Care

Virginia’s 2018 HIV Continuum of Care (HCC) is a framework used to monitor health outcomes of persons living with HIV in Virginia from initial diagnosis to viral suppression. The 2018 HCC below presents these definitions:



Care marker A "care marker" is defined as a CD4, viral load, or genotype testing lab, an HIV medical care visit, or an antiretroviral (ART) prescription; these are considered markers for evidence of HIV care
Persons living with HIV as of 12/31/2018 The number of persons aware of their status, diagnosed and living with HIV with a last known residence in Virginia as of 12/31/2018
Newly diagnosed and linked to HIV care within 30 days Persons newly diagnosed in Virginia in 2018 and linked to HIV care within 30 days from initial diagnosis
Evidence of HIV care in 2018 Persons living with HIV as of 12/31/2018 who had at least one care marker in calendar year (CY) 2018
Retained in HIV care in 2018 Persons living with HIV as of 12/31/2018 who had at least two care markers at least 3 months (90 days) apart in CY 2018
Virally suppressed in 2018 Persons living with HIV as of 12/31/2018 with their most recent viral load in CY 2017 measuring at <200 copies/milliliter (mL)

 All data presented for Virginia’s 2018 HCC comes from the Care Markers Database within the Division of Disease Prevention. Data are reported as of December 2018 and accessed January 2019. Data are still considered preliminary. 

Data to Care

Regional Statistics

(Data as of July 2015 updated November 2015)


Estimating HIV Incidence


Didn’t find what you were looking for? Click here to request data not routinely made available.

STD Surveillance Reports


Atlas: CDC’s National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention (NCHHSTP) interactive tool allowing users to create maps, charts and tables using nationwide HIV/AIDS and STD surveillance data

Didn’t find what you were looking for? Click here to request data not routinely made available.

Funded agencies are required to engage in Monitoring & Evaluation activities. Monitoring & Evaluation is an embedded concept and an essential component of every DDP HIV Prevention project or program.

  • Monitoring is a systematic and routine collection of data from HIV Prevention programs and interventions. Monitoring allows agencies to check their progress against their plans. The data acquired through monitoring are used for evaluation.
  • Evaluation is assessing — as systematically and objectively as possible — the quality and effectiveness of a program or intervention. Evaluation allows agencies to determine not only if intended outcomes are being met, but also how and why these outcomes are being met. This information is used in ongoing planning processes.

In addition to quarterly progress reports, funded agencies are required to use EvaluationWeb to collect key monitoring data. EvaluationWeb is an online data collection system created and managed through Luther Consulting. Funded agencies should maintain an accurate and complete set-up of their programs in EvaluationWeb, including informing DDP when interventions, sites, and users need to be added or removed. The Add Site and Add Intervention forms should be used in this process.

Funded agencies are responsible for using EvaluationWeb regularly and correctly. DDP is committed to assisting funded agencies with this process. The link below will take you to an EvaluationWeb Orientation Packet. This packet is a toolkit for new staff to acquaint themselves with the database, and for existing staff to review for ongoing guidance. Additionally, technical assistance and training is available from DDP.

Another useful resource is the EvaluationWeb help page, particularly the User Guides and Quick References section.

Please follow the instructions below for requesting information related to morbidity reports of HIV/AIDS/STDs in Virginia.

Important Notes Regarding HIV and STD Data Requests:

  • It is important to note that HIV data is not final until 12 months following diagnosis date. Data on sexually transmitted diseases (STD; chlamydia, gonorrhea, syphilis) are considered complete in May following the close of the year.
  • To maintain confidentiality, suppression may be warranted for certain data where population size and/or number of cases are too small to report. Zip codes in Virginia are subject to change over time; therefore, requests for number of cases or rates by zip code may not be an accurate geographic unit of measure.
  • Rates for a partial year of data are not calculated.
  • Requests for data below the county level must be reviewed by DDP management and approved on a case-by-case basis. Data requests that are especially complex may be subject to the conditions of the Freedom of Information Act (FOIA) and a charge for staff time may be warranted. Data to be used for research purposes may require review by the VDH Institutional Review Board (IRB).